Benjamin Besse, MD, PhD, is a professor and head of Clinical Research at Institute Gustave Roussy, Villejuif, France. He earned his medical degree from Paris Medical School. He completed a residency and fellowship in medical oncology at Assistance Publique-Hôpitaux de Paris, and a doctoral fellowship in molecular biology at Institute Català d’Oncologia, Barcelona, Spain. He earned his PhD in oncogenesis from Paris Saclay University.
Professor Besse’s research focus is lung cancer immunotherapy, including immunologic prognostic and predictive factors and clinical and radiologic patterns of response to immunotherapy. He is also interested in the applicability of liquid biopsy in lung cancer, including molecular diagnosis and monitoring, early detection of residual disease, and personalised medicine according to liquid biopsy molecular profile. He is a member of the French National Institute of Health and Medical Research (INSERM) Unit 981. He has served as coordinator of international clinical trials from phase I to phase III.
Professor Besse is chair of the European Organisation for Research and Treatment of Cancer (EORTC)’s Scientific Chair Council, chair of the French National Thymus Network RYTHMIC, and a member of international societies, including the International Association for the Study of Lung Cancer, the American Society of Clinical Oncology (ASCO), and the European Society for Medical Oncology (ESMO). Recognition of his work includes an ASCO Merit Award and an ESMO fellowship for translational research. His work has appeared in numerous peer-reviewed publications, including Lancet Oncology, JAMA Oncology, Journal of Thoracic Oncology, Lung Cancer, European Journal of Cancer, Leukemia & Lymphoma, and Annals of Oncology. He is a member of the Annals of Oncology editorial committee.